Fresenius SE & Co. KGaA (FRE):企業のM&A・提携動向(医療機器分野)

GlobalDataが発行した調査報告書(GDME698D)
◆英語タイトル:Fresenius SE & Co. KGaA (FRE) - Medical Equipment - Deals and Alliances Profile
◆商品コード:GDME698D
◆発行会社(リサーチ会社):GlobalData
◆発行日:2016年2月24日
◆ページ数:66
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary

Fresenius SE & Co. KGaA (Fresenius) is a global health care group, which offers products and services for dialysis treatment. It provides various dialysis services through its own clinics and sells its products to other dialysis service providers. Its major products and services includes machines for hemodialysis, acute dialysis and peritoneal dialysis; solutions for infusion therapy; dialysis care services; Spectra laboratories; liver support therapy services; and provision projects and services for hospitals and other health care facilities. It also operates and manages acute care and postacute care hospitals in Germany through Helios Kliniken Group. Its major manufacturing plants are in the US, Germany, China, Sweden and Japan. Fresenius conducts operations in Asia-Pacific, Europe, Africa and the Americas. The company is headquartered in Bad Homburg, Germany.

Fresenius SE & Co. KGaA (FRE) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Fresenius SE & Co. KGaA, Medical Equipment, Deals By Year, 2010 to YTD 2016 7
Fresenius SE & Co. KGaA, Medical Equipment Deals By Type, 2010 to YTD 2016 8
Fresenius SE & Co. KGaA, Medical Equipment, Deals By Region, 2010 to YTD 2016 9
Fresenius SE & Co. KGaA, Medical Equipment, Deals By Market, 2010 to YTD 2016 10
Fresenius SE & Co. KGaA, Medical Equipment, Deals Summary, 2010 to YTD 2016 11
Fresenius SE & Co. KGaA, Medical Equipment, Deal Details 14
Asset Purchase 14
Fresenius Kabi USA Acquires US Pharma Plant and Ready to Administer Drugs from Becton, Dickinson 14
Fresenius Medical Care Completes Acquisition Of International Dialysis Centers From Euromedic International 15
Fresenius Medical Care Acquires Crit-Line System Assets From Hema Metrics 17
Fresenius Medical Care Acquires Worldwide Peritoneal Dialysis Business From Gambro 18
Fresenius Medical Care Canada Acquires Rights For NephroCare Software From Cybernius Medical 19
Fresenius Medical Care Acquires Dialysis Stations From Hand Prod 20
Partnerships 21
Fresenius Medical Care Extends Licensing Agreement with Interface Biologics 21
Debiotech and Fresenius Medical Care Enter into Agreement 22
Verax Biomedical Enters into Commercialization Agreement with Fresenius Kabi USA 23
Sequana Medical Enters into Distribution Agreement with Fresenius Medical Care 24
Toray Industries Enters into Distribution Agreement with Fresenius Medical Care 25
JMS North America Enters Into Distribution Agreement With Fresenius Medical Care For AVF Needles 26
Fresenius Medical Care Enters Into An Agreement With NIKKISO 27
Equity Offering 28
Fresenius Plans Private Placement Of Shares For US$1.3 Billion 28
Debt Offering 29
Fresenius Raises USD300 Million in Private Placement of Notes 29
Fresenius Medical Care Raises USD500 Million in Private Placement of 4.125% Notes Due 2020 30
Fresenius Medical Care Raises USD400 Million in Private Placement of 4.75% Notes Due 2024 31
Fresenius Medical Care Raises USD518 Million in Private Placement of Convertible Bonds 32
Fresenius Increases Size Of Private Placement Of Notes Due 2024 For US$611.4 Million 33
Fresenius Completes Private Placement Of Notes Due 2019 For US$407.6 Million 34
Fresenius Completes Private Placement Of Notes Due 2021 For US$611.4 Million 35
Fresenius Medical Care Prices Private Placement Of Notes Due 2020 For US$673 Million 36
Fresenius Medical Care Completes Private Placement Of 5.625% Senior Unsecured Notes Due 2019 For US$800 Million 38
Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2019 For US$316.4 Million 39
Fresenius Medical Care Completes Private Placement Of 5.875% Senior Unsecured Notes Due 2022 For US$700 Million 40
Fresenius Medical Care Completes Private Placement Of Floating-Rate Senior Notes Due 2016 For US$133.7 Million 41
Fresenius Medical Care Completes Private Placement Of Senior Unsecured Notes Due 2018 For US$550 Million 42
Fresenius Medical Care Completes Private Placement Of Senior Unsecured Notes Due 2018 For US$400 Million 43
Fresenius Medical Care Completes Private Placement Of 5.75% Senior Unsecured Notes Due 2021 For US$650 Million 44
Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2021 For US$403 Million 45
Fresenius Medical Care Completes Private Placement Of Senior Notes For US$360.42 Million 46
Asset Transactions 47
Fresenius Medical to Divest Dialysis Services Unit in Venezuela 47
Fresenius Medical Care Divests Fresenius Medical care Dialysis Clinic for USD1.4 Million 48
Acquisition 49
Fresenius Kabi Completes Acquisition Of Fenwal From TPG Capital And Maverick Capital For US$1.1 Billion 49
Fresenius Acquires 70% Stake In Huangshi Lishizhen Medicine Group Wuhan Xisu Pharma From Huangshi Lishizhen Medicine Group Wuhan Lishizhen Medicine 51
Fresenius Medical Care to Acquire Nefrocontrol 52
Fresenius Medical Care To Acquire Nikkiso Medical Korea From NIKKISO 53
Fresenius SE & Co. KGaA – Key Competitors 54
Key Employees 55
Locations And Subsidiaries 56
Head Office 56
Other Locations & Subsidiaries 56
Recent Developments 60
Financial Announcements 60
Jul 29, 2015: Fresenius Medical Care Reports Second Quarter 2015 Results And Confirms Guidance For Full Year 2015 60
Apr 29, 2015: Fresenius Medical Care reports first quarter 2015 results and confirms guidance for full year 2015 62
Feb 25, 2015: Fresenius Medical Care reports fourth quarter and full year 2014 results 63
Appendix 66
Methodology 66
About GlobalData 66
Contact Us 66
Disclaimer 66

List of Tables
Fresenius SE & Co. KGaA, Medical Equipment, Key Facts, 2014 1
Fresenius SE & Co. KGaA, Medical Equipment, Deals Summary, 2010 to YTD 2016 1
Fresenius SE & Co. KGaA, Medical Equipment, Deals By Year, 2010 to YTD 2016 7
Fresenius SE & Co. KGaA, Medical Equipment Deals By Type, 2010 to YTD 2016 8
Fresenius SE & Co. KGaA, Medical Equipment, Deals By Region, 2010 to YTD 2016 9
Fresenius SE & Co. KGaA, Deals By Market, 2010 to YTD 2016 10
Fresenius SE & Co. KGaA, Medical Equipment, Deals Summary, 2010 to YTD 2016 11
Fresenius Kabi USA Acquires US Pharma Plant and Ready to Administer Drugs from Becton, Dickinson 14
Fresenius Medical Care Completes Acquisition Of International Dialysis Centers From Euromedic International 15
Fresenius Medical Care Acquires Crit-Line System Assets From Hema Metrics 17
Fresenius Medical Care Acquires Worldwide Peritoneal Dialysis Business From Gambro 18
Fresenius Medical Care Canada Acquires Rights For NephroCare Software From Cybernius Medical 19
Fresenius Medical Care Acquires Dialysis Stations From Hand Prod 20
Fresenius Medical Care Extends Licensing Agreement with Interface Biologics 21
Debiotech and Fresenius Medical Care Enter into Agreement 22
Verax Biomedical Enters into Commercialization Agreement with Fresenius Kabi USA 23
Sequana Medical Enters into Distribution Agreement with Fresenius Medical Care 24
Toray Industries Enters into Distribution Agreement with Fresenius Medical Care 25
JMS North America Enters Into Distribution Agreement With Fresenius Medical Care For AVF Needles 26
Fresenius Medical Care Enters Into An Agreement With NIKKISO 27
Fresenius Plans Private Placement Of Shares For US$1.3 Billion 28
Fresenius Raises USD300 Million in Private Placement of Notes 29
Fresenius Medical Care Raises USD500 Million in Private Placement of 4.125% Notes Due 2020 30
Fresenius Medical Care Raises USD400 Million in Private Placement of 4.75% Notes Due 2024 31
Fresenius Medical Care Raises USD518 Million in Private Placement of Convertible Bonds 32
Fresenius Increases Size Of Private Placement Of Notes Due 2024 For US$611.4 Million 33
Fresenius Completes Private Placement Of Notes Due 2019 For US$407.6 Million 34
Fresenius Completes Private Placement Of Notes Due 2021 For US$611.4 Million 35
Fresenius Medical Care Prices Private Placement Of Notes Due 2020 For US$673 Million 36
Fresenius Medical Care Completes Private Placement Of 5.625% Senior Unsecured Notes Due 2019 For US$800 Million 38
Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2019 For US$316.4 Million 39
Fresenius Medical Care Completes Private Placement Of 5.875% Senior Unsecured Notes Due 2022 For US$700 Million 40
Fresenius Medical Care Completes Private Placement Of Floating-Rate Senior Notes Due 2016 For US$133.7 Million 41
Fresenius Medical Care Completes Private Placement Of Senior Unsecured Notes Due 2018 For US$550 Million 42
Fresenius Medical Care Completes Private Placement Of Senior Unsecured Notes Due 2018 For US$400 Million 43
Fresenius Medical Care Completes Private Placement Of 5.75% Senior Unsecured Notes Due 2021 For US$650 Million 44
Fresenius Medical Care Completes Private Placement Of 5.25% Senior Unsecured Notes Due 2021 For US$403 Million 45
Fresenius Medical Care Completes Private Placement Of Senior Notes For US$360.42 Million 46
Fresenius Medical to Divest Dialysis Services Unit in Venezuela 47
Fresenius Medical Care Divests Fresenius Medical care Dialysis Clinic for USD1.4 Million 48
Fresenius Kabi Completes Acquisition Of Fenwal From TPG Capital And Maverick Capital For US$1.1 Billion 49
Fresenius Acquires 70% Stake In Huangshi Lishizhen Medicine Group Wuhan Xisu Pharma From Huangshi Lishizhen Medicine Group Wuhan Lishizhen Medicine 51
Fresenius Medical Care to Acquire Nefrocontrol 52
Fresenius Medical Care To Acquire Nikkiso Medical Korea From NIKKISO 53
Fresenius SE & Co. KGaA, Key Competitors 54
Fresenius SE & Co. KGaA, Key Employees 55
Fresenius SE & Co. KGaA, Other Locations 56
Fresenius SE & Co. KGaA, Subsidiaries 56

List of Figures
Fresenius SE & Co. KGaA, Medical Equipment, Deals by Type, 2010 to YTD 2016 1
Fresenius SE & Co. KGaA, Medical Equipment, Deals By Year, 2010 to YTD 2016 1
Fresenius SE & Co. KGaA, Medical Equipment, Deals By Region, 2010 to YTD 2016 1
Fresenius SE & Co. KGaA, Medical Equipment, Deals By Market, 2010 to YTD 2016 1
Fresenius SE & Co. KGaA, Medical Equipment, Deals By Year, 2010 to YTD 2016 7
Fresenius SE & Co. KGaA, Medical Equipment, Deals by Type, 2010 to YTD 2016 8
Fresenius SE & Co. KGaA, Medical Equipment, Deals By Region, 2010 to YTD 2016 9
Fresenius SE & Co. KGaA, Medical Equipment, Deals by Market, 2010 to YTD 2016 10

【掲載企業】

DaVita HealthCare Partners Inc.
Nipro Corporation
Baxter International Inc.
Behn Meyer Europe GmbH
VAMED AG
Geratherm Medical AG

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Fresenius SE & Co. KGaA (FRE):企業のM&A・提携動向(医療機器分野)(Fresenius SE & Co. KGaA (FRE) - Medical Equipment - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆